FutuRx is a company headquartered in Israel. Brouky records 2 investors associated with the company.
FutuRx is an Israel-based biotechnology venture studio that builds and supports early-stage biopharma companies, translating scientific discoveries into therapeutic programs. The group partners with industry investors (e.g., Takeda Ventures, OrbiMed Israel Partners) to create and advance portfolio companies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.